- Home
- CETX vs INM Comparison
CETX vs INM Comparison
Compare CETX & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CETX
- INM
- Stock Information
- Founded
- CETX 1998
- INM 1981
- Country
- CETX United States
- INM Canada
- Employees
- CETX N/A
- INM N/A
- Industry
- CETX EDP Services
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- CETX Technology
- INM Health Care
- Exchange
- CETX Nasdaq
- INM Nasdaq
- Market Cap
- CETX 2.7M
- INM 2.3M
- IPO Year
- CETX 1998
- INM N/A
- Fundamental
- Price
- CETX $1.48
- INM $2.08
- Analyst Decision
- CETX
- INM
- Analyst Count
- CETX 0
- INM 0
- Target Price
- CETX N/A
- INM N/A
- AVG Volume (30 Days)
- CETX 39.5K
- INM 15.0K
- Earning Date
- CETX 05-13-2025
- INM 05-13-2025
- Dividend Yield
- CETX N/A
- INM N/A
- EPS Growth
- CETX N/A
- INM N/A
- EPS
- CETX N/A
- INM N/A
- Revenue
- CETX $63,725,617.00
- INM $4,832,013.00
- Revenue This Year
- CETX $19.77
- INM N/A
- Revenue Next Year
- CETX $15.00
- INM N/A
- P/E Ratio
- CETX N/A
- INM N/A
- Revenue Growth
- CETX N/A
- INM N/A
- 52 Week Low
- CETX $1.40
- INM $1.99
- 52 Week High
- CETX $8,484.00
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- CETX 36.15
- INM 26.67
- Support Level
- CETX $1.45
- INM $1.99
- Resistance Level
- CETX $1.74
- INM $2.66
- Average True Range (ATR)
- CETX 0.12
- INM 0.15
- MACD
- CETX 0.03
- INM -0.05
- Stochastic Oscillator
- CETX 23.81
- INM 9.34
About CETX Cemtrex Inc.
Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.